The Organisation of Pharmaceutical Producers of India (OPPI), which represents multinational pharma companies in the country, has joined issue with the forces who are opposing the efforts of the developed nations at WIPO for the patent harmonization which is feared to undermine the flexibilities available under TRIPS.
The details can be read here.
No comments:
Post a Comment